Formulation and characterization of erythromycin–loaded solid lipid nanoparticles

Biointerface Research in Applied Chemistry

Volumn 7, Issue 5, 2017, Pages 2145-2150

  Pignatello, Rosario ^a   Fuochi, Virginia ^a   Petronio, Giulio Petronio ^b   Greco, Antonio S ^a   Furneri, Pio Maria ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b IRCCS SAN RAFFAELE PISANA   (Italy)

Author keywords

Cationic SLN; Drug Delivery; Erythromcyin; In vitro activity; In vitro antibacterial activity; MIC; Minimum Inhibitory Concentration (MIC); Solid lipid nanoparticles (SLN)

Indexed keywords

EID: 85047562679     PISSN: None     EISSN: 20695837     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Muller R.H., Lippacher A., Gohala S. Solid lipid nanoparticles (SLN) as carrier system for the controlled release of drugs. In: Handbook of pharmaceutical controlled release technology. M. Dekker, pp. 377-391, 2000.
2. Svilenov H., Tzachev C. Solid Lipid Nanoparticles-A promising Drug Delivery System. In: Seifealian A., de Mel A., Kalaskar D.M. (Eds.), Nanomedicine, London pp. 187-237, 2014.
3. Carbone C., Cupri S., Leonardi A., Puglisi G., Pignatello R. Lipid-based nanocarriers for drug delivery and targeting: a patent survey of methods of production and characterization. Pharmaceutical Patent Analyst, 2(5), 665-677, 2013.
4. Doktorovova S., Shegokar R., Souto E.B. Role of excipients in formulation development and biocompatibility of lipid nanoparticles (SLNs/NLCs). In: Ficai A., Grumezesku A.M. (Eds.), Nanostructures for Novel Therapy – Synthesis, Characterization and Applications, Elsevier, Chapter 30, pp. 811-843, 2017.
5. Leonardi, A., Bucolo, C., Drago, F., Salomone, S., Pignatello, R. Cationic solid lipid nanoparticles enhance ocular hypotensive effect of melatonin in rabbit. International Journal of Pharmaceutics, 478(1), 180-186, 2015.
6. Bondì M.L., Azzolina A., Craparo E.F., Lampiasi N., Capuano G., Giammona G., Cervello M. Novel cationic solid-lipid nanoparticles as non-viral vectors for gene delivery. Journal of Drug Targeting, 15(4), 295-301, 2007.
7. Rehman Z., Zuhorn I.S., Hoekstra D. How cationic lipids transfer nucleic acids into cells and across cellular membranes: recent advances. Journal of Controlled Release, 166 (1), 46-56, 2013.
8. Furneri P.M., Petronio Petronio G., Fuochi V., Pignatello R. Nanosized devices as antibiotics and antifungals delivery: past, news, and outlook. In: Andronescu E., Grumezescu A.M. (Eds.), Nanostructures for Drug Delivery, Elsevier, Chapter 23, pp. 697–748, 2017.
9. Hayden S.C., Zhao G., Saha K., Phillips R.L., Li X., Miranda O.R., Rotello V.M., El-Sayed M.A., Schmidt-Krey I., Bunz U.H.F. Aggregation and interaction of cationic nanoparticles on bacterial surfaces. Journal of the American Chemical Society, 134 (16), 6920–6923, 2012.
10. st Ed, Academic Press, 1984.
11. ndEd, Academic Press Inc.,2002.
12. Devrim B., Bozkir A., Nanocarriers and Their Potential Application as Antimicrobial Drug Delivery. In: Ficai A., Grumezesku A.M. (Eds.), Nanostructures for Antimicrobial Therapy, Elsevier, Chapter 7, pp.169-202, 2017.
13. Schubert M.A., Muller-Goymann C.C. Solvent injection as a new approach for manufacturing lipid nanoparticles – evaluation of the method and process parameters. European Journal of Pharmaceutics and Biopharmaceutics, 55(1), 125-131, 2003.
14. Finete V.L.M., Arissawa M., Aucélio R.Q. Fluorimetric method for the determination of erythromycin using a photochemical derivatization approach. Journal of the Brazilian Chemical Society, 19(7), 1418-1422, 2008
15. Fass, R.J., & Barnishan, J. Minimal inhibitory concentrations of antimicrobial agents for control strains Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853. Antimicrobial Agents and Chemotherapy, 16(5), 622-624, 1979.
16. th Ed. CLSI supplement M100 (ISBN 1-56238-804-5 [Print]; ISBN 1-56238-805-3 [Electronic]). Clinical and Laboratory Standards Institute, 950 West Valley Road, Suite 2500, Wayne, Pennsylvania 19087 USA, 2017.
17. Fresta, M., Puglisi, G., Giammona, G., Cavallaro, G., Micali, N., & Furneri, P. M. Pefloxacine mesilate‐and ofloxacin‐loaded polyethylcyanoacrylate nanoparticles: Characterization of the colloidal drug carrier formulation. Journal of Pharmaceutical Sciences, 84(7), 895-902, 1995.
18. Sahu A.K., Kumar T., Jain V. Formulation optimization of erythromycin Solid Lipid Nanocarrier using response surface methodology. BioMed Research International, vol. 2014, Article ID 689391, 8 pages, 2014.
19. Pignatello R., Mangiafico A., Ruozi B., Puglisi G, Furneri P.M., Amphiphilic erythromycin-lipoamino acid ion pairs: characterization and in vitro microbiological evaluation, AAPS PharmSciTech 12 (2), 468-475, 2011.
20. Botequim, D., Maia, J., Lino, M. M. F., Lopes, L. M. F., Simoes, P. N., Ilharco, L. M., & Ferreira, L. Nanoparticles and surfaces presenting antifungal, antibacterial and antiviral properties. Langmuir, 28(20), 7646-7656, 2012.
21. Fresta, M., Furneri, P. M., Mezzasalma, E., Nicolosi, V. M., & Puglisi, G. Correlation of trimethoprim and brodimoprim physicochemical and lipid membrane interaction properties with their accumulation in human neutrophils. Antimicrobial Agents and Chemotherapy, 40(12), 2865-2873, 1996.